These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6318302)

  • 41. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
    Weigle KA; Grose C
    J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.
    Trlifajová J; Svejcar J; Svandová E; Ryba M; Pekárek J
    Acta Virol; 1980 Dec; 24(6):406-14. PubMed ID: 6111201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid.
    Gershon A; Steinberg S; Greenberg S; Taber L
    J Clin Microbiol; 1980 Dec; 12(6):764-7. PubMed ID: 6273449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
    Geiser CF; Bishop Y; Myers M; Jaffe N; Yankee R
    Cancer; 1975 Apr; 35(4):1027-30. PubMed ID: 46775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.
    Terada K; Kawano S; Yoshihiro K; Morita T
    Scand J Infect Dis; 1993; 25(6):775-8. PubMed ID: 8052820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia.
    Steele RW; Myers MG; Vincent MM
    N Engl J Med; 1980 Aug; 303(7):355-9. PubMed ID: 6248780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serological responses in varicella and zoster assayed by immunoblotting.
    Harper DR; Kangro HO; Heath RB
    J Med Virol; 1988 Aug; 25(4):387-98. PubMed ID: 2844983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy.
    Cristófani LM; Weinberg A; Peixoto V; Boas LS; Marques HH; Maluf Júnior PT; Pannuti C; Oselka GW; Amato Neto V; Odone-Filho V
    Vaccine; 1991 Dec; 9(12):873-6. PubMed ID: 1667345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.
    Asano Y; Takahashi M
    Biken J; 1978 Mar; 21(1):15-23. PubMed ID: 208504
    [No Abstract]   [Full Text] [Related]  

  • 55. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.
    Gershon AA; Steinberg SP
    Infect Immun; 1979 Jul; 25(1):170-4. PubMed ID: 225270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
    Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
    Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
    Gershon AA; Mervish N; LaRussa P; Steinberg S; Lo SH; Hodes D; Fikrig S; Bonagura V; Bakshi S
    J Infect Dis; 1997 Dec; 176(6):1496-500. PubMed ID: 9395360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Varicella zoster immunoglobulin. Prophylactic use in risk patients].
    Geursen RG
    ZFA (Stuttgart); 1983 Mar; 59(7):342-7. PubMed ID: 6303013
    [No Abstract]   [Full Text] [Related]  

  • 59. [Management of varicella-zoster virus infections. No systematic vaccination against varicella in France].
    Lorette G
    Presse Med; 1998 Jul 4-11; 27(24):1237. PubMed ID: 9767786
    [No Abstract]   [Full Text] [Related]  

  • 60. Live attenuated Varicella-Zoster vaccine.
    Gershon AA
    Rev Infect Dis; 1980; 2(3):393-407. PubMed ID: 6158080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.